Back to Search Start Over

Gilead's remdesivir data 'highly encouraging,' says Wells Fargo

Source :
The Fly. April 13, 2020
Publication Year :
2020

Abstract

Wells Fargo analyst Jim Birchenough remains optimistic regarding prospects for Gilead's remdesivir success in treating COVID-19 following NEJM publication of initial compassionate use results in hospitalized patients with severe COVID-19. [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
The Fly
Publication Type :
Periodical
Accession number :
edsgcl.620383560